https://www.ibtomato.com/ExternalView.aspx?type=1&no=18665IB토마토ko2026-06-19T19:03:02+09:00깨끗한나라, BBB- 강등에 회사채 고비…한 달 뒤 '만기 폭탄'https://www.ibtomato.com/ExternalView.aspx?type=1&no=18670IB토마토ko2026-06-19T17:39:37+09:00(Deal클립)세아제강, 수요 몰리며 증액…상환 부담 덜었다https://www.ibtomato.com/ExternalView.aspx?type=1&no=18664IB토마토ko2026-06-19T17:31:48+09:00(공시톺아보기)IPO 대신 스팩…기업가치는 누가 정할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=18660IB토마토ko2026-06-19T14:37:16+09:00(크레딧시그널)애큐온캐피탈, 자산 늘렸지만 건전성은 뒷걸음https://www.ibtomato.com/ExternalView.aspx?type=1&no=18655IB토마토ko2026-06-18T18:13:57+09:00동서식품, 원가 부담에도 10% 이익률…'카누 바리스타'가 버팀목https://www.ibtomato.com/ExternalView.aspx?type=1&no=18639IB토마토ko2026-06-18T17:27:12+09:00메타랩스, 60억 유증 자금 메타케어로…계열사 거래 독립성 논란https://www.ibtomato.com/ExternalView.aspx?type=1&no=18638IB토마토ko2026-06-18T17:18:50+09:00(은행권 승계전)②오너 고객 잡고 CIB 딜까지 노린다https://www.ibtomato.com/ExternalView.aspx?type=1&no=18649IB토마토ko2026-06-18T17:13:21+09:00이지케어텍, 영업익 127% 늘고도 현금흐름 적자 전환https://www.ibtomato.com/ExternalView.aspx?type=1&no=18640IB토마토ko2026-06-18T17:09:13+09:00아이엠증권, 단기조달 급증…소송·중앙그룹 리스크 '설상가상'https://www.ibtomato.com/ExternalView.aspx?type=1&no=18650IB토마토ko2026-06-18T16:53:51+09:00(크레딧시그널)LG생활건강, 실적 부진에도 순현금 1조 돌파https://www.ibtomato.com/ExternalView.aspx?type=1&no=18637IB토마토ko2026-06-18T16:44:58+09:00HLB제약, GLP-1 특허 방어 실패…SMEB 프리미엄 유지할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=18647IB토마토ko2026-06-18T16:09:29+09:00(공시톺아보기)기업은 왜 보유 토지를 다시 평가할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=18646IB토마토ko2026-06-18T16:06:30+09:00(크레딧시그널)SPC삼립, 시화공장 사고 여파…수익성 '흔들'https://www.ibtomato.com/ExternalView.aspx?type=1&no=18643IB토마토ko2026-06-18T16:00:39+09:00(성과주의 균열)①성과급 잔치 뒤 번지는 계열사 박탈감https://www.ibtomato.com/ExternalView.aspx?type=1&no=18645IB토마토ko2026-06-18T19:00:00+09:00(합정역 7번출구)AI 잘 쓰는 직장인, 연봉도 더 받는다https://www.ibtomato.com/ExternalView.aspx?type=1&no=18644IB토마토ko2026-06-18T10:45:19+09:00문래동4가, 삼성물산·대우건설 맞손…지산 공실 리스크는 여전https://www.ibtomato.com/ExternalView.aspx?type=1&no=18641IB토마토ko2026-06-18T10:25:31+09:00롯데온, 또 희망퇴직…이커머스 축소 신호탄 되나https://www.ibtomato.com/ExternalView.aspx?type=1&no=18631IB토마토ko2026-06-17T18:35:13+09:00삼현, 신사업 투자에 현금흐름 악화…수익화 속도가 관건https://www.ibtomato.com/ExternalView.aspx?type=1&no=18636IB토마토ko2026-06-17T18:16:05+09:00미래에셋캐피탈, 배당수익 735억…1분기 만에 연간 순익 육박https://www.ibtomato.com/ExternalView.aspx?type=1&no=18632IB토마토ko2026-06-17T18:10:00+09:00모아텍, 매출 늘어도 5년째 적자…원가율 90%가 발목https://www.ibtomato.com/ExternalView.aspx?type=1&no=18635IB토마토ko2026-06-17T18:02:58+09:00(공시톺아보기)'소액'이라 가볍게 보면 안 되는 공모 공시https://www.ibtomato.com/ExternalView.aspx?type=1&no=18624IB토마토ko2026-06-17T17:48:45+09:00상상인증권, 엔젠바이오 유증 완주할까…20% 실권수수료가 변수https://www.ibtomato.com/ExternalView.aspx?type=1&no=18628IB토마토ko2026-06-17T17:24:56+09:00(수주만 큰 설계사)③파트너라더니 하청 신세…턴키·PF의 그늘https://www.ibtomato.com/ExternalView.aspx?type=1&no=18626IB토마토ko2026-06-17T17:19:48+09:00스톤브릿지운용, 자본금 1억 1인 법인에 매각…인수자 실체 논란https://www.ibtomato.com/ExternalView.aspx?type=1&no=18627IB토마토ko2026-06-17T16:53:30+09:00진원생명과학, 영업 회복 요원…관리종목 지정 '경고등'https://www.ibtomato.com/ExternalView.aspx?type=1&no=18633IB토마토ko2026-06-17T16:46:36+09:00(유증레이다)LB세미콘, 495억 유증…후공정 회복 올라탈까https://www.ibtomato.com/ExternalView.aspx?type=1&no=18610IB토마토ko2026-06-17T16:40:39+09:00카카오뱅크, 달러박스 접고 외화통장 승부…후발주자 한계 넘을까https://www.ibtomato.com/ExternalView.aspx?type=1&no=18634IB토마토ko2026-06-17T16:21:00+09:00오리온, 임금합의안 올해 적용…기본급 3.5% 인상https://www.ibtomato.com/ExternalView.aspx?type=1&no=18629IB토마토ko2026-06-17T11:03:00+09:00(IB&피플)이예나 법무법인 율촌 변호사https://www.ibtomato.com/ExternalView.aspx?type=1&no=18630IB토마토ko2026-06-17T10:39:38+09:00(크레딧시그널)하나증권, 발행어음 날개에도 부동산금융 85% 부담https://www.ibtomato.com/ExternalView.aspx?type=1&no=18625IB토마토ko2026-06-17T10:34:03+09:00AK홀딩스, AKIS 중심 재편…유통·AI 결합 승부수https://www.ibtomato.com/ExternalView.aspx?type=1&no=18623IB토마토ko2026-06-17T08:00:00+09:00(알림)'2026 경영전략컨퍼런스' 개최…경제안보 시대 대응전략은